Patents by Inventor Magnus Gram

Magnus Gram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
    Patent number: 10350268
    Abstract: Medical use of alpha-1-microglobulin (A1M) in the treatment or prophylaxis of diseases wherein oxidative stress is a responsible factor in the progress of the disease. Notably, the present invention relates to the medical use of alpha-1-microglobulin in the treatment or prophylaxis of diseases or conditions associated with the presences of free radicals and/or free haemoglobin in the subject.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: July 16, 2019
    Assignee: A1M PHARMA AB
    Inventors: Bo Åkerström, Stefan Hansson, Martin Lennarth Olsson, Magnus Gram
  • Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
    Patent number: 10226507
    Abstract: The present invention relates to alpha-1-microglobulin for use in the treatment of a mitochondria-related disease.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: March 12, 2019
    Assignee: A1M PHARMA AB
    Inventors: Bo Åkerstrom, Magnus Gram, Lena Rosenlöf
  • ALPHA-1-MICROGLOBULIN FOR USE IN THE TREATMENT OF MITOCHONDRIA-RELATED DISEASES
    Publication number: 20150258171
    Abstract: The present invention relates to alpha-1-microglobulin for use in the treatment of a mitochondria-related disease.
    Type: Application
    Filed: September 4, 2013
    Publication date: September 17, 2015
    Applicant: A1M Pharma AB
    Inventors: Bo Åkerstrom, Magnus Gram, Lena Rosenlöf
  • HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
    Publication number: 20130122529
    Abstract: A method for diagnosing or predicting the risk of developing preeclampsia by measuring the level of A1 M and one or more of the compounds HbA, HbF in a sample and comparing the obtained values with reference values. By using a combination of information relating to A1 M and HbF improved diagnose or prediction is observed.
    Type: Application
    Filed: March 24, 2011
    Publication date: May 16, 2013
    Applicant: Preelumina Diagnostics AB
    Inventors: Bo Akerstrom, Magnus Gram, Stefan Hansson